Siriraj Medical Journal

Corrigendum to: The Relationship Between Primary Caregivers’ Psychosocial Factors and Self-esteem in Children and Adolescents with ADHD: An Exploratory Cross-sectional Study

2026-07-17T11:11:50+07:00

This corrigendum relates to the following article: Wannapaschaiyong P, Penphattarakul A, Rojmahamongkol P, Sutchritpongsa S. The Relationship Between Primary Caregivers’ Psychosocial Factors and Self-Esteem in Children and Adolescents with ADHD: An Exploratory Cross-sectional Study. Siriraj Med J. 2023;75(8):584–591.DOI: https://doi.org/10.33192/smj.v75i8.263447

URL: https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/263447

The author would like to correct the error in the publication of the original article⁽¹⁾ and has informed the editor to correct as follows:

Content of Correction:

Incorrect: The COA number in the article:

COA no. Si 661/2022 (IRB1)

Correct:

COA no. Si 661/2022

Corrigendum to: Sleep Habits and Behavioral Problems in Preschool-aged Children with ADHD

2026-07-17T10:59:48+07:00

This corrigendum relates to the following article: Wannapaschaiyong P, Penphattarakul A, Rojmahamongkol P, Sutchritpongsa S. Sleep Habits and Behavioral Problems in Preschool-aged Children with ADHD. Siriraj Med J. 2024;76(3):116–124. DOI: https://doi.org/10.33192/smj.v76i3.267462

URL: https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/267462

The author would like to correct the error in the publication of the original article⁽¹⁾ and has informed the editor to correct as follows:

Content of Correction:

Incorrect: The COA number in the article:
COA no. Si 719/2023 (IRB3)

Correct:
COA no. Si 719/2023

Corrigendum to: Effectiveness of Ayurved Siriraj Prasa-Nam-Nom Recipe on Breast Milk Volume in Early Postpartum Women: A Randomized, Double- Blind, Placebo-Controlled Trial

2026-07-10T11:12:10+07:00

This Corrigendum relates to the following article: Chanprapaph P, Thippayacharoentam C, Iam-am A, Lumlerdkij N, Akarasereenont P, Laohapand T, Bangkha S, Kumleemak N, Piyophirapong S, Nimmannit A, Thippayacharoentam T. Effectiveness of Ayurved Siriraj Prasa-Nam-Nom Recipe on Breast Milk Volume in Early Postpartum Women: A Randomized, Double-Blind, Placebo- Controlled Trial. Siriraj Med J. 2022;74(1):11–18. DOI: https://doi.org/10.33192/Smj.2022.2

URL: https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/255495

The author would like to correct the error in the publication of the original article¹and has informed the editor to correct as follows:

Content of Correction:
Incorrect Study design in the article:
between November 2010 and December 2012

Correct Study design:
between August 2012 and February 2014

Cost-Effectiveness Analysis of Rimegepant Versus Eletriptan for Patients with Acute Episodic Migraine in Thailand: Establishing Dominance from a Societal Perspective

2026-07-01T10:16:13+07:00

Objective: For acute migraine patients unresponsive to sumatriptan, the choice is between another triptan, eletriptan, and the novel CGRP antagonist, rimegepant. As of now, no cost-effectiveness analysis comparing rimegepant and eletriptan has been conducted in Thailand. This study aims to evaluate the cost-effectiveness of rimegepant and eletriptan for the treatment of acute episodic migraine in Thailand using data from the Thai healthcare system.

Materials and Methods: This study was a health economic evaluation using a lifetime decision tree–Markov model with 30-day cycles, from a societal perspective. Total costs and quality-adjusted life years (QALYs) were projected using effectiveness data from a systematic review, cost data from Thai healthcare databases, and utility values from published literature. The incremental cost-effectiveness ratio (ICER) was evaluated, and uncertainty was assessed through sensitivity analyses.

Results: The results revealed that, using a 3% discount rate and 2025 costs, the total cost of treatment with rimegepant for acute episodic migraine in Thailand was 2,442,622.42 THB, yielding 25.21 QALYs. In comparison, treatment with eletriptan incurred a total cost of 2,450,782.33 THB and yielded 17.59 QALYs. The ICER of rimegepant compared with eletriptan was −1,071.79 THB per QALY gained. Therefore, rimegepant was considered a dominant strategy, as it generated more QALYs while incurring lower overall costs than eletriptan.

Conclusion: Rimegepant has demonstrated cost-effectiveness in treating acute episodic migraine in Thailand, as it is a dominant strategy, generating higher QALYs while incurring lower overall costs. This economic evidence would help policymakers make informed decisions.

Impact of Air Pollution on Acne Vulgaris: A Systematic Review

2026-07-05T20:27:21+07:00

Objective: This study aimed to systematically review the existing evidence of the impact of air pollutants on acne vulgaris.

Materials and Methods: The studies assessed the relationship between air pollution and acne, in terms of the number of acne lesions, severity of acne, number of patients who visited the hospital with acne complaints, and impact on quality of life, which were the eligibility criteria for the outcome of this study. The studies that were not in the English language, case reports, conference abstracts, and studies with duplicate publication data were excluded. Risk of Bias in Non-randomized Studies (ROBINS-E) was used to assess the risk of bias. Descriptive analysis was conducted because of different outcomes reported among the studies.

Results: 226 articles were identified through the literature search. Four studies were included. El Haddad, et al, reported that NO₂ exposure aggravated acne vulgaris. Xiang Li, et al, presented that exposure to Particulate matter10 (PM10), sulfur dioxide (SO₂), and nitrogen dioxide (NO2) in Xi’an, China, as well as PM2.5 in Chongqing, China showed inconclusive results regarding increases in outpatient visits of acne vulgaris. Wei Liu, et al. demonstrated that exposure to SO₂ decreases the outpatient visits of acne vulgaris.

Conclusion: PM2.5, PM10 and SO₂ presented controversial outcomes. Since current studies had a risk of bias and methodological limitations, a prospective cohort or panel studies using personal or high-resolution exposure estimates, standardized measures of acne incidence and severity, prespecified lag periods, and adjustment of confounders were suggested for a better understanding of the correlation.